Clinical Trial Update: CX3CR1+T Cell Predict Immunotherapy Efficacy

View source ↗

Summary

A completed clinical trial from Shanghai Pulmonary Hospital explored whether CX3CR1+ T cells can predict the efficacy of immunotherapy in non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Non-small Cell Lung Cancer | Status: COMPLETED